Mingxuan Feng

2.1k total citations
48 papers, 1.3k citations indexed

About

Mingxuan Feng is a scholar working on Surgery, Molecular Biology and Hepatology. According to data from OpenAlex, Mingxuan Feng has authored 48 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Surgery, 18 papers in Molecular Biology and 17 papers in Hepatology. Recurrent topics in Mingxuan Feng's work include Liver Disease and Transplantation (8 papers), Organ Transplantation Techniques and Outcomes (8 papers) and Pediatric Hepatobiliary Diseases and Treatments (6 papers). Mingxuan Feng is often cited by papers focused on Liver Disease and Transplantation (8 papers), Organ Transplantation Techniques and Outcomes (8 papers) and Pediatric Hepatobiliary Diseases and Treatments (6 papers). Mingxuan Feng collaborates with scholars based in China, Sweden and United States. Mingxuan Feng's co-authors include Zhigang Zhang, Qiang Xia, Xiaomei Yang, Yahui Wang, Jun Li, Jianren Gu, Wenxin Qin, Shu‐Heng Jiang, Yanli Zhang and Zhenjun Zhao and has published in prestigious journals such as Gastroenterology, Hepatology and Cancer Research.

In The Last Decade

Mingxuan Feng

45 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingxuan Feng China 16 857 488 210 151 126 48 1.3k
Hong Shu China 22 780 0.9× 309 0.6× 245 1.2× 177 1.2× 122 1.0× 94 1.4k
Junhong Zhao China 19 805 0.9× 469 1.0× 244 1.2× 120 0.8× 129 1.0× 32 1.2k
Tiantian Zou China 15 683 0.8× 507 1.0× 129 0.6× 130 0.9× 258 2.0× 29 1.2k
Limei Liu China 22 1.1k 1.3× 507 1.0× 565 2.7× 125 0.8× 148 1.2× 42 1.7k
JiHoon Kang South Korea 21 642 0.7× 476 1.0× 493 2.3× 275 1.8× 136 1.1× 63 1.4k
Masayuki Nagahashi Japan 14 503 0.6× 287 0.6× 394 1.9× 178 1.2× 122 1.0× 27 1.0k
Changwei Dou China 22 1.2k 1.4× 852 1.7× 334 1.6× 245 1.6× 198 1.6× 46 1.8k

Countries citing papers authored by Mingxuan Feng

Since Specialization
Citations

This map shows the geographic impact of Mingxuan Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingxuan Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingxuan Feng more than expected).

Fields of papers citing papers by Mingxuan Feng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingxuan Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingxuan Feng. The network helps show where Mingxuan Feng may publish in the future.

Co-authorship network of co-authors of Mingxuan Feng

This figure shows the co-authorship network connecting the top 25 collaborators of Mingxuan Feng. A scholar is included among the top collaborators of Mingxuan Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingxuan Feng. Mingxuan Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wu, Huimin, Hao Ji, Yi Luo, et al.. (2024). Clinical outcomes of Omicron infection and vaccine acceptance among pediatric liver transplant recipients: insights from a cross-sectional survey. Virology Journal. 21(1). 299–299. 1 indexed citations
3.
Chen, Fang, Chuan Shen, Mingxuan Feng, et al.. (2024). High intra-patient variability of tacrolimus within post-operative 1 month predicted worse 1-year outcomes in pediatric liver transplant recipients. European Journal of Clinical Pharmacology. 80(7). 1017–1027. 6 indexed citations
4.
5.
6.
Wang, Min, Yi Luo, Ping Wan, et al.. (2022). Low COVID‐19 vaccine coverage and guardian acceptance among pediatric transplant recipients. Journal of Medical Virology. 95(1). e28377–e28377. 7 indexed citations
7.
Zhao, Zhenjun, Helge Gad, Carlos Benitéz‐Buelga, et al.. (2021). NEIL3 Prevents Senescence in Hepatocellular Carcinoma by Repairing Oxidative Lesions at Telomeres during Mitosis. Cancer Research. 81(15). 4079–4093. 20 indexed citations
8.
Wang, Tianyi, Mingxuan Feng, Xinyu Wan, et al.. (2021). Successful Treatment of Pediatric Refractory Burkitt Lymphoma PTLD after Liver Transplantation using Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy. Cell Transplantation. 30. 2139989353–2139989353. 19 indexed citations
9.
Hou, Yuchen, Ping Wan, Mingxuan Feng, et al.. (2021). Modified Dual Hepatic Vein Anastomosis in Pediatric Living-Donor Liver Transplantation Using Left Lateral Segment Grafts With Two Wide Orifices. Frontiers in Pediatrics. 9. 685956–685956. 3 indexed citations
10.
Zhao, Zhenjun, Kang He, Yu Zhang, et al.. (2021). XRCC2 repairs mitochondrial DNA damage and fuels malignant behavior in hepatocellular carcinoma. Cancer Letters. 512. 1–14. 20 indexed citations
11.
Feng, Mingxuan, Ping Wan, Bijun Qiu, et al.. (2020). Hepatic artery reconstruction in pediatric liver transplantation: Experience from a single group. Hepatobiliary & pancreatic diseases international. 19(4). 307–310. 7 indexed citations
12.
Hou, Jiajie, He Zhang, Jun Liu, et al.. (2019). YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma. Molecular Cancer. 18(1). 268 indexed citations
13.
Sanjiv, Kumar, Helge Gad, Therese Pham, et al.. (2019). Karonudib is a promising anticancer therapy in hepatocellular carcinoma. Therapeutic Advances in Medical Oncology. 11. 3862482000–3862482000. 22 indexed citations
14.
Dong, Fangyuan, Qin Yang, Zheng Wu, et al.. (2019). Identification of survival-related predictors in hepatocellular carcinoma through integrated genomic, transcriptomic, and proteomic analyses. Biomedicine & Pharmacotherapy. 114. 108856–108856. 14 indexed citations
15.
Yang, Xiaomei, Xiaoyan Cao, Ping He, et al.. (2018). Overexpression of Rac GTPase Activating Protein 1 Contributes to Proliferation of Cancer Cells by Reducing Hippo Signaling to Promote Cytokinesis. Gastroenterology. 155(4). 1233–1249.e22. 90 indexed citations
16.
Wang, Qiang, Jian Mo, Chenchen Zhao, et al.. (2018). Raddeanin A suppresses breast cancer-associated osteolysis through inhibiting osteoclasts and breast cancer cells. Cell Death and Disease. 9(3). 376–376. 32 indexed citations
17.
Feng, Mingxuan, Qiang Wang, Min Zhu, et al.. (2016). Dihydroartemisinin prevents breast cancer-induced osteolysis via inhibiting both breast caner cells and osteoclasts. Scientific Reports. 6(1). 19074–19074. 49 indexed citations
18.
Feng, Mingxuan & Dun Hong. (2015). [Update on prevention of epidural adhesion after lumbar laminectomy].. PubMed. 28(11). 1064–8. 3 indexed citations
19.
Fu, Ying, Jun Li, Mingxuan Feng, et al.. (2014). Cytohesin-3 is upregulated in hepatocellular carcinoma and contributes to tumor growth and vascular invasion.. PubMed. 7(5). 2123–32. 15 indexed citations
20.
Feng, Mingxuan, Mingze Ma, Ying Fu, et al.. (2014). Elevated autocrine EDIL3 protects hepatocellular carcinoma from anoikis through RGD-mediated integrin activation. Molecular Cancer. 13(1). 226–226. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hong Shu Breakdown of academic impact, for papers by Junhong Zhao Breakdown of academic impact, for papers by Tiantian Zou Breakdown of academic impact, for papers by Limei Liu Breakdown of academic impact, for papers by JiHoon Kang Breakdown of academic impact, for papers by Masayuki Nagahashi Breakdown of academic impact, for papers by Changwei Dou
Rankless by CCL
2026